Stock listing
SCYX Stock Price, News, Filings & Events — Scynexis, Inc.
Selected listing: SCYX · NASDAQ · USD · US
This page tracks Scynexis, Inc.'s SCYX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SCYX:NASDAQ. SCYX:NASDAQ is the stock-level entry point for investors researching Scynexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Scynexis, Inc. is a public company traded under the ticker SCYX in the American market. The company has a market capitalization of approximately $37 million. Scynexis focuses on developing innovative therapies for serious infections, particularly in the area of antifungal treatments.
- Ticker
- SCYX:NASDAQ
- Asset type
- Stock
- Market cap
- $53.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Scynexis, Inc. SCYX:NASDAQ stock context
This page tracks Scynexis, Inc.'s SCYX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SCYX:NASDAQ. SCYX:NASDAQ is the stock-level entry point for investors researching Scynexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Scynexis, Inc. is a public company traded under the ticker SCYX in the American market. The company has a market capitalization of approximately $37 million. Scynexis focuses on developing innovative therapies for serious infections, particularly in the area of antifungal treatments.
Latest news from Scynexis, Inc.
SCYNEXIS to Participate in Upcoming Investor Conferences
September 1, 2026
SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
August 25, 2026
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 10, 2026
SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (AD...
June 30, 2026
SCYNEXIS Announces One-for-Eight Reverse Stock Split
May 22, 2026
Scynexis, Inc. earnings calls
SCYNEXIS, Inc. (SCYX) Q3 2022 Earnings Call
November 9, 2022 · Replay with transcript and chapters
SCYNEXIS, Inc. (SCYX) Q2 2022 Earnings Call
August 15, 2022 · Replay with transcript and chapters
SCYNEXIS, Inc. (SCYX) Q1 2022 Earnings Call
May 12, 2022 · Replay with transcript and chapters
SCYNEXIS, Inc. (SCYX) Q3 2021 Earnings Call
November 10, 2021 · Replay with transcript and chapters
Research Scynexis, Inc.
Scynexis, Inc. investor report
Review AI stock analysis and investor report context for SCYX:NASDAQ.
Scynexis, Inc. company profile
View the public company page for Scynexis, Inc. on 6ix.
Scynexis, Inc. news
Read company news and market updates connected to Scynexis, Inc..
Scynexis, Inc. investor events
Find investor webinars, events, and replay context for Scynexis, Inc..
Alternate listings
A2P9T4:LSX
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
135A:GETTEX
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
A2P9T4:LS
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
0L49:LSE
GB · USD
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
SCYX:BOATS
US · USD
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
135A:FWB
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
135A:DUS
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
135A:MUN
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
135A:SWB
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.
135A:TRADEGATE
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is SCYX:NASDAQ.